找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Experimental and Applied Immunotherapy; Jeffrey Medin,Daniel Fowler Book 2011 Springer Science+Business Media, LLC 2011 Cancer.Immunothera

[復(fù)制鏈接]
樓主: 搖尾乞憐
31#
發(fā)表于 2025-3-26 21:50:53 | 只看該作者
Dendritic Cell-Based Cancer Vaccines: Practical Considerationsions of cell-based immunotherapy. Specific issues include optimization and standardization of cell specific products, identification of ideal patients and cancer subtypes as well as methods to comprehensively evaluate the host response and more fully understand underlying biological effectors that are engaged.
32#
發(fā)表于 2025-3-27 02:15:16 | 只看該作者
Negative Regulators in Cancer Immunology and Immunotherapy and immunotherapy. In this chapter, we describe some of these immunosuppressive mechanisms and components that are linked in complex networks. A better understanding of these mechanisms will eventually lead to improvements of cancer immunotherapies.
33#
發(fā)表于 2025-3-27 06:46:52 | 只看該作者
34#
發(fā)表于 2025-3-27 10:35:47 | 只看該作者
Combining Cancer Vaccines with Conventional Therapiesese issues and results from recent experiments demonstrating the combining vaccination with surgical resection or chemotherapy can greatly enhance the activity of cancer vaccines in situations of large tumor burden.
35#
發(fā)表于 2025-3-27 15:39:50 | 只看該作者
Extending the Use of Adoptive T Cell Immunotherapy for Infections and Cancerections (e.g., cytomegalovirus [CMV], Epstein-Barr virus [EBV], and adenovirus) and virus-associated diseases, such as EBV-associated lymphoproliferative disease (LPD), that arise in the immunocompromised host. This therapeutic approach has also been extended to the treatment of cancer and has shown
36#
發(fā)表于 2025-3-27 21:00:16 | 只看該作者
B Lymphocytes in Cancer Immunologys with solid tumors harbor circulating antitumor antibodies and most tumors contain a population of infiltrating B cells implying an association between oncogenic events and B-cell activation. B-cell immunity can be beneficial by providing antibody-mediated protection from oncogenic viruses or a sou
37#
發(fā)表于 2025-3-27 23:30:25 | 只看該作者
38#
發(fā)表于 2025-3-28 03:22:36 | 只看該作者
Natural Killer Cells for Cancer Immunotherapyatively underrepresented in the medical literature, due in part to the strong emphasis placed on studying the mechanisms of the antigenic specificity and memory of T and B lymphocytes. Fortunately, as innate cells have gained prominence in recent years, NK cell research has blossomed and we now have
39#
發(fā)表于 2025-3-28 07:02:33 | 只看該作者
40#
發(fā)表于 2025-3-28 14:05:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 08:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
康定县| 安康市| 邯郸县| 沙雅县| 新竹县| 博乐市| 辉南县| 乌拉特前旗| 天长市| 民乐县| 名山县| 府谷县| 巴彦淖尔市| 巴东县| 沁阳市| 上蔡县| 资源县| 东阿县| 张家川| 潼南县| 布尔津县| 志丹县| 勃利县| 白朗县| 伊春市| 丽江市| 方山县| 无棣县| 衡东县| 杭锦旗| 丘北县| 正宁县| 慈利县| 栾川县| 中牟县| 马公市| 德昌县| 河源市| 晋州市| 丘北县| 林口县|